Eloralintide And Tirzepatide
AMPLIFY-1
Eli Lilly · Phase 3 · Not yet recruiting · Enrollment 2115
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| EloraTZP Dose 1 | n/r | n/r | n/r | n/r | n/r |
| EloraTZP Dose 2 | n/r | n/r | n/r | n/r | n/r |
| EloraTZP Dose 3 | n/r | n/r | n/r | n/r | n/r |
| EloraTZP Dose 4 | n/r | n/r | n/r | n/r | n/r |
| EloraTZP Dose 5 | n/r | n/r | n/r | n/r | n/r |
| Tirzepatide | n/r | n/r | n/r | n/r | n/r |
| Eloralintide | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.